ESC 365 - When is the best time to act upon (subclinical) AF in which patient?

Open Access

When is the best time to act upon (subclinical) AF in which patient?

Session: Atrial fibrillation (AF) management - how does novel technology help to address this comprehensive task?

Topic: Atrial Fibrillation (AF)

Speaker: Professor T. Deneke (Nuremberg, DE)

Sponsored by BIOTRONIK

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Professor Thomas Deneke

Hospital Nurenberg North, Nuremberg (Germany)

16 presentations

3 followers

4 more presentations in this session

Welcome.

Speaker: Professor C. Sticherling (Basel, CH)

Opportunities to manage the AF screening process.

Speaker: Professor D. Linz (Maastricht, NL)

State-of-the-art opportunities in rhythm control.

Speaker: Professor I. Deisenhofer (Munich, DE)

AF management - how does novel technology help to address this comprehensive task? - Q&A and panel discussion.

Access the full session

Atrial fibrillation (AF) management - how does novel technology help to address this comprehensive task?

Speakers: Professor T. Deneke, Professor C. Sticherling, Professor D. Linz, Professor I. Deisenhofer

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources